← Evidence map

TrialStroke2023

Study of Rivaroxaban for Cerebral Venous Thrombosis: A Randomized Controlled Feasibility Trial Comparing Anticoagulation With Rivaroxaban to Standard-of-Care in Symptomatic Cerebral Venous Thrombosis.

Thalia S Field et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

29 papers cite it

2023
2024
2025
2026
this paperpooled itcites it

2 trials

Full record →Abstract, authors, funding and every citing paper · PMID 37675613